156 related articles for article (PubMed ID: 34328113)
21. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
22. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
[TBL] [Abstract][Full Text] [Related]
24. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
25. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
28. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases.
Li H; Christman LM; Li R; Gu L
Food Funct; 2020 Jun; 11(6):4878-4891. PubMed ID: 32490857
[TBL] [Abstract][Full Text] [Related]
29. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights.
Chen W; Chen H; Fu S; Lin X; Zheng Z; Zhang J
Bioprocess Biosyst Eng; 2021 May; 44(5):929-939. PubMed ID: 32458051
[TBL] [Abstract][Full Text] [Related]
30. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
Reinisch W
Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
[TBL] [Abstract][Full Text] [Related]
31. The Microbiome in Patients With Inflammatory Diseases.
Somineni HK; Kugathasan S
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
[TBL] [Abstract][Full Text] [Related]
32. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P
Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
Shamoon M; Martin NM; O'Brien CL
Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review.
Cao WT; Huang R; Jiang KF; Qiao XH; Wang JJ; Fan YH; Xu Y
World J Gastroenterol; 2021 Mar; 27(9):886-907. PubMed ID: 33727776
[TBL] [Abstract][Full Text] [Related]
35. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
36. Predictive values of colon microbiota in the treatment response to colorectal cancer.
Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
[TBL] [Abstract][Full Text] [Related]
37. Fecal Transplant in Inflammatory Bowel Disease.
Browne AS; Kelly CR
Gastroenterol Clin North Am; 2017 Dec; 46(4):825-837. PubMed ID: 29173524
[TBL] [Abstract][Full Text] [Related]
38. Psoriasis and Gut Microbiome-Current State of Art.
Polak K; Bergler-Czop B; Szczepanek M; Wojciechowska K; Frątczak A; Kiss N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926088
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.
Gubatan J; Holman DR; Puntasecca CJ; Polevoi D; Rubin SJ; Rogalla S
World J Gastroenterol; 2021 Nov; 27(43):7402-7422. PubMed ID: 34887639
[TBL] [Abstract][Full Text] [Related]
40. Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease.
Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Bonovas S
Aliment Pharmacol Ther; 2020 May; 51(9):820-830. PubMed ID: 32170782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
